Table 1.
Clinical Features of Patients With Lung Cancer with COVID-19 as Reported in Published Studies
| Study | Total Patients | Fever, N (%) |
Cough, N (%) |
Dyspnea, N (%) | Myalgia, N (%) | Fatigue, N (%) | Gastrointestinal Symptoms, N (%) |
|---|---|---|---|---|---|---|---|
| Peng et al. 20208 | 7 | 7 (100) | 7 (100) | 7 (100) | — | 7 (100) | 1 (14) |
| Rogado et al. 202051 | 17 | 12 (71) | 17 (100) | 13 (77) | 5 (29) | — | 1 (6) |
| Luo et al. 202042 | 69 | 42 (70)a | 47 (77)b | 43 (73)c | — | — | 13 (22)a |
| Yu et al. 202010 | 7 | 7 (100) | 3 (43) | 3 (43) | — | — | — |
| Cai et al. 202025 | 6 | 6 (100) | 4 (67) | 0 (0) | 2 (33) | 2 (33) | 0 (0) |
| Garassino et al. 202014 | 200 | 127 (64)d | 103 (52)d | 106 (54)d | 10 (5)d | 54 (27)d | 10 (5)d |
| Total | 306 | 201/295 (68) | 181/296 (61) | 172/294 (59) | 17/221 (8) | 63/211 (30) | 25/288 (9) |
Note: Total patients are defined as the total number of patients with lung cancer and COVID-19 included in the study.
COVID-19, coronavirus disease 2019.
a
Percentages are calculated on the basis of 60 patients with reported symptoms in the study.
b
Percentage is calculated on the basis of 61 patients with reported symptoms in the study.
c
Percentage is calculated on the basis of 59 patients with reported symptoms in the study.
d
Percentages are calculated on the basis of 198 patients with reported symptoms in the study.